Elderly, Vulnerable Will Need Yearly COVID-19 Boosters, WHO Says: Report

The World Health Organization predicts that vulnerable people will need yearly COVID-19 vaccine boosters and the everyday population will need shots every two years, according to an internal document, Reuters reported Thursday.

The document, Reuters reported, is an assessment set to be discussed Thursday at a board meeting of Gavi, a public-private partnership between health agencies, pharmaceutical companies, research institutions and non-profit organizations. The assessment recommends vulnerable people, such as the elderly, receive annual COVID-19 vaccine boosters, and the general population receive boosters every two years.

The document said boosters were necessary due to the emergence of new COVID-19 variants, and that vaccines would need to be regularly updated, according to Reuters, though the document did not show how these conclusions were reached.

Read More

Commentary: Pandemic Lockdowns Were a Public Health Mistake

More evidence to confirm what many Republican lawmakers and free-market advocates such as Americans for Limited Government were saying from the start of the Covid pandemic, lockdowns would be one of the most tragic mistakes in American history.

The Rand Corporation and economists from the University of Southern California have released a new study examining the effectiveness of pandemic lockdowns, using data from 43 countries and all 50 US states.

“We fail to find that shelter-in-place policies saved lives,” the authors report. In the weeks following the implementation of these policies, excess mortality actually increases—even though it had typically been declining before the orders took effect.

And across all countries, the study finds that a one-week increase in the length of stay-at-home policies corresponds with 2.7 more excess deaths per 100,000 people.

Read More

U.S. Government Allocates $3.2 Billion for COVID-19 Antiviral Pills

Department of Health & Human Services

The Department of Health and Human Services will invest $3.2 billion to develop and manufacture COVID-19 antiviral medicines, it announced Thursday.

The initiative, funded as part of the American Rescue Plan, is designed to accelerate research into antivirals as well as build platforms for urgent response to future viral threats, the Department of Health and Human Services (HHS) said in a statement Thursday. Specifically, the plan expands antiviral clinical trials, forms partnerships between health agencies and pharmaceutical companies, and funds “drug discovery groups” tasked with innovating new antiviral medicines.

“New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives,” said chief medical adviser Dr. Anthony Fauci in the statement.

Read More

Study Finds Novavax COVID-19 Vaccine 90 Percent Effective

Doctor preparing COVID-19 Vaccine

Novavax announced on Monday that its two-dose COVID-19 vaccine is 90% effective, according to a press release on Novavax’s website.

The phase-3 trial enrolled 29,960 participants ages 18 and older in the U.S. and Mexico. The study found that 77 of the participants tested positive for COVID-19, with 63 testing positive in the placebo group and 14 in the vaccine group, according to the press release.

“Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines. These clinical results reinforce that NVX-CoV2373 is extremely effective and offers complete protection against both moderate and severe COVID-19 infection,” Stanley C. Erck, President, and CEO of Novavax said in the press release.

Read More

U.S. Investigates Possible Leak at Chinese Nuclear Power Plant, Report

Nuclear power plant

The U.S. is reportedly investigating a possible leak at a China nuclear power plant in the city of Taishan.

The possible leak was reported to U.S. officials by the French company Framatome, which helps to operate the plant. Framatone has also accused the China of raising the acceptable limits of radiation detection to avoid shutting the plant down, as first reported Monday by CNN.

The company reportedly made a request June 3 for operational safety assistance, which would allow it to “address an urgent safety matter” because the Chinese plant was leaking fission gas.

The company said China has raised the detection limits to double what it had determined.

Read More

Facebook Forks over $75K to Georgia State for Anti-Racist Virtual Reality Simulation

Girl with VR headset on

Facebook gave Georgia State University $75,000 to create a narrative film experience about racism.

Georgia State University’s School of Public Health received the grant from Facebook Reality Labs — the technology company’s virtual reality arm — to “create a narrative film that will be an immersive and interactive online platform for combating racial injustice.”

The initiative is meant to “increase viewers’ empathy and enhance their understanding of racism and structural inequality” through augmented and virtual reality technologies.

Read More

American Higher Education Has Deep Ties to EcoHealth Alliance, Wuhan Institute of Virology

Person holding bottle of COVID Vaccine

Several American researchers have worked with the Wuhan Institute of Virology and EcoHealth Alliance on coronavirus-related research, including gain of function research, dating back more than a decade, and emails reveal that several professors were in contact with Dr. Anthony Fauci during the early stages of the coronavirus pandemic. 

As the intelligence community commences its investigation into the origins of SARS-CoV-2, a series of scientific papers and studies belie a close relationship between American academia and the Wuhan lab, as well as EcoHealth Alliance, the multinational organization through which the NIH sent $600,000 to study the transmission of coronaviruses.  

What follows is a brief timeline of research publications on which university researchers collaborated with partners from the Wuhan Institute of Virology and EcoHealth Alliance. 

Read More